Our News
Sydney’s AXT offers Organ-on-Chip systems in Asia Pacific region
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment. The agreement will see AXT distribute CN Bio’s innovative bioengineering products to medical...
read moreCN Bio to bring 10 organs together on a chip
London Organ-on-Chip specialist CN Bio today announced it has secured an exclusive license to technology from the Massachusetts Institute of Technology for Organ-on-Chip systems which connect human tissues from up to 10 organs. CN Bio participated with MIT on a...
read morePhysioMimix™ Human 3D Cell Culture wins Lab Innovation 2018 Award
The PhysioMimix™ benchtop 3D cell culture system from CN Bio has won the Innovation Award at the UK’s largest laboratory event, held at the NEC Birmingham in November. PhysioMimix™ allows researchers to set up assays and generate results quickly. Scientists and...
read moreCN Bio Innovations’ Board names David Hughes as next Chief Executive Officer
London, UK, 19 July 2018: CN Bio Innovations Limited today announced that its Board of Directors has accepted the resignation of Dr Emma Sceats as CEO and Director of CN Bio and appointed Dr David Hughes as Chief Executive Officer effective immediately. Dr Hughes has...
read moreOrgan-on-Chip Webinar: Improving Preclinical Studies for Faster Drug Development
View this webinar by industry specialists Xtalks to discover how to run Organ-on-a-Chip studies in your own lab to enhance research. The webinar covers: Walkthrough of an Organ-on-Chip workflow: lab set-up, seeding and culturing cells, dosing, sampling and analysis...
read moreCN Bio launches PhysioMimix benchtop Human-Body-on-a-Chip device
London, UK, 23 May 2018: CN Bio Innovations Limited today launched PhysioMimix, a printer-sized device which allows scientist to conduct organ-on-chip studies in their own labs, testing new drugs and chemicals on living human organ models. Dr Emma Sceats, CEO of CN...
read moreRadio 4’s PM features CN Bio Human Organ-on-Chips
Listen to Radio 4’s flagship PM programme with Caroline Quinn interview CN Bio Innovations’ CEO Dr Emma Sceats. Emma describes London-based CN Bio’s organ-on-chips: miniature devices that help researchers re-create the structure and function of human organs in the...
read moreCN Bio and MIT announce 10 Organ-On-Chip Platform: Nature Scientific Reports
Organ-on-Chip specialist CN Bio's microfluidic platform for improving drug evaluation has taken a significant step forward. CN Bio's partners at MIT today published details of the platform which successfully connects engineered tissues from up to 10 organs, accurately...
read moreCN Bio MicroMix to be featured at AACR
Dr David Hughes, Chief Technical Officer at Organ-on-Chip specialist CN Bio Innovations will be presenting a poster at the American Association for Cancer Research Annual Meeting 2018. The poster will cover the company’s MicroMix technology. MicroMix uses pumps and...
read morePharmaVentures Interview: Will Organ-on-Chip technology provide the data Regulators need in the future?
As new drug treatments are developed, quicker and much more precise technology which predicts the effect these chemical and biological substances have on human organs are also becoming available. These technologies will be important particularly for pharmaceutical and...
read more